Group items tagged

Analysis of opinions drawn from leading pharmaceutical industry executives.Provides revenue growth expectations for the period 2012-2013. Provides growth prospects and changes in the competitive landscape in terms of mergers and acquisitions and business structure. Analysis of the demand in emerging markets and growth expectations in developed countries.Analysis of the changing business dynamics in the pharmaceutical industry. Analysis of the challenges faced by buyers and suppliers. This report is the result of an extensive survey drawn from ICD Research's exclusive panel of leading pharmaceutical industry executives. It analyzes how business strategies and practices in the pharmaceutical industry are set to change in 2012-13. This report gives you access to the category-level supplier selection criteria, business challenges and investment opportunities for leading purchase decision makers. The report also identifies future growth of buyers and suppliers, M&A and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and size.

"Active Pharmaceutical Ingredients (API) in the U.S. market for 2016 - Growth in biotechnology and generic segments and pharmaceutical patents Cliff Committee will shape the landscape" provides a detailed overview on the U.S. market API. The research provides a detailed analysis and forecasts for major economic and market trends affecting the API markets in this region.

The report includes the pharmaceutical and health products Slovakia Business Monitor International (BMI) of '5 and 10 years for products and estimates of health expenditure and imports and exports,

Asia-Pacific region is now the pharmaceutical industry growing fastest in the world arena pharmaceuticals. Low labor and manufacturing costs have attracted significant investment from global giants.

Croatia Pharmaceuticals and Health Report provides Business Monitor International (BMI) of '5 and 10 years for drugs and estimates of health expenditure and imports and exports, with a focus on the prospects for growth for the prescription, OTC, patented drugs and generics market segments.

BMI Belgian pharmaceutical and health Report provides industry professionals, investors and market analysts, business and financing independent forecasts and competitive intelligence is a drug and Belgian health sector.

Latvia Pharmaceuticals and Health Report features Business Monitor International (BMI) of '5 and 10 years for products and estimates of health expenditure and imports and exports, focusing on the growth outlook for prescription drug sales free and generic market segments.

Microfluidics Market by Material (Polymer, Glass, Silicon) Application (Pharmaceutical (Genomics, Proteomics, Capillary Electrophoresis) Diagnostic (POC, Clinical, Environmental, Industrial) Drug Delivery (Inhaler, Micropump)) - Global Forecast to 2020 is a market research report available at US $4650 for a Single User PDF License from RnR Market Research Reports Library.

Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom Oligos, Reagent, Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global Forecast to 2020 is a market research report available at US $4650 for a Single User PDF License from RnR Market Research Reports Library.

In a highly competitive market, pharmaceutical drug manufacturers are faced with several industry issues including the expiry of blockbuster drug patents, increasing government legislation and a lack of new drugs in the development pipeline.

The Thailand Medication & Medical Document features Business Monitor International (BMI)'s 5 and 10-year estimates for medication and health care costs and imports and exports

Medication in Denmark market profile is an essential resource for top-level details and research covering the Medication market. It features details on market dimension and segmentation, plus textual and graphic research of the key trends and very competitive landscape designs, major organizations and group details.

Medication in North america industry profile is an essential resource for top-level information and research covering the Medication industry.

The Asia-Pacific is now the fastest pharmaceutical industry growth in the global pharmaceutical arena. Low manufacturing and labor costs have attracted large investments from global giants. For example, GSK, Pfizer with other pharmaceutical companies have opened manufacturing plants in South Korea and other countries in the region.

Canada is one of the largest pharmaceutical market, even if you have a small share of only 3% of worldwide pharmaceutical industry. In 2010, generics accounted for more than 57% of prescriptions and 26% of total pharmaceutical sales.

We provide business intelligence, market insights and competitor analysis to serve business leaders in industry, biotech, pharmaceutical, government departments and hi-tech organisations.

In 2009, China's government announced plans to invest RMB1.13 trillion ($180 billion) in expanding and improving healthcare provision, through significant healthcare reforms. This massive spending program is rapidly expanding healthcare access for China's 1.3 billion citizens, and has implications for the pharmaceutical industry worldwide. Inside China's Healthcare Reforms: Opportunities for Multinational Pharma This comprehensive report goes deep inside China to reveal the ways that recent reforms are changing healthcare for rural and urban citizens. Numerous local experts have been consulted for their insights, including industry experts, government officials, ministry advisers, and formulary managers. The reader-friendly report explores each key aspect of healthcare reform in turn, clearly explaining what it is, why it was needed, and what progress has been made so far, and then summarising its specific implications for the Pharma industry. As well as covering recent reforms, the report also examines key reform priorities through to 2015.

Presentation of the costs of programs, rules and rising health care market and pharmaceutical contributing to growth in the Middle East and Africa in the pharmaceutical industry.

* Risk * Urology * Waste Management BROWSE CATEGORIES Advertising & Marketing Agriculture Automotive Aviation/Aerospace Banking and Finance Biotechnology Business Consumer Goods Drinks Energy & Resources FMCG Food & Beverages Infrastructure Insurance Law Manufacturing & Construction Materials & Chemicals Metals and Minerals Pharmaceuticals & Healthcare Plastic Publishing Retail Research Shipping Telecommunications & IT Textiles Tourism Report detail Home > Market Research Reports > Pharmaceuticals & Healthcare > Asia Pacific Biotechnology Market (2008-2012) Asia Pacific Biotechnology Market (2008-2012) PDF Format Asia Pacific Biotechnology Market (2008-2012) Published : June 2011 No.of Pages : 165 :: Enquire before buying :: Email to a friend Free Market Research Reports Alerts Register Now :: Printer friendly page Quick Buy Area Price : US$ 1,552.00 Add to Cart - (Asia Pacific Biotechnology Market (2008-2012)) Site License : US$ 2,328.00 Add to Cart - (Asia Pacific Biotechnology Market (2008-2012)) Change Currency : usd gbp eur Bookmark and Share Buy through us and save. We do not add any Tax / Duty including VAT,GST Asia Pacific Biotechnology Market (2008-2012) The Asia Pacific biotechnology market is one with immense potential, which can be tapped through investments driving the infrastructure and R&D in the sector. Investments in the past have been the main reason behind the sustained double digit growth in the biotech sector of the region.

Cell-based Assays Market by Product (Cell Lines, Reagents, Kits, Instruments, Software, Services), Applications (Research, Drug Discovery, ADME Studies, Toxicology), End User (Pharmaceutical Companies, Academics, CRO), & Region - Global Forecast to 2020